Search for persons
X
?
1
Clinical characteristics of the study cohort (n = 47):
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/dataset/Clinical_characteristics_of_the_study_cohort_n_47_/21832475. , 2023
https://figshare.com/articles/dataset/Clinical_characteristics_of_the_study_cohort_n_47_/21832475. , 2023
?
2
Difference in T cell receptor (TCR) characteristics between..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Difference_in_T_cell_receptor_TCR_characteristics_between_ascites_of_patients_grouped_in_Cluster_A_and_ascites_of_patients_grouped_in_the_remaining_clusters_others_/21832421. , 2023
https://figshare.com/articles/journal_contribution/Difference_in_T_cell_receptor_TCR_characteristics_between_ascites_of_patients_grouped_in_Cluster_A_and_ascites_of_patients_grouped_in_the_remaining_clusters_others_/21832421. , 2023
?
3
Association of immune characteristics determined by flow cy..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/figure/Association_of_immune_characteristics_determined_by_flow_cytometry_and_T_cell_receptor_TCR_sequencing_with_patient_prognosis_/21832460. , 2023
https://figshare.com/articles/figure/Association_of_immune_characteristics_determined_by_flow_cytometry_and_T_cell_receptor_TCR_sequencing_with_patient_prognosis_/21832460. , 2023
?
4
Cox proportional hazards models of flow cytometry and T cel..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Cox_proportional_hazards_models_of_flow_cytometry_and_T_cell_receptor_characteristics_with_a_prognostic_value_independent_of_debulking_status_/21832445. , 2023
https://figshare.com/articles/journal_contribution/Cox_proportional_hazards_models_of_flow_cytometry_and_T_cell_receptor_characteristics_with_a_prognostic_value_independent_of_debulking_status_/21832445. , 2023
?
5
Increased T cell receptor productive rearrangements in asci..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Increased_T_cell_receptor_productive_rearrangements_in_ascites_of_patients_with_i_BRCA1_2_i_tumor_mutations_/21832430. , 2023
https://figshare.com/articles/journal_contribution/Increased_T_cell_receptor_productive_rearrangements_in_ascites_of_patients_with_i_BRCA1_2_i_tumor_mutations_/21832430. , 2023
?
6
Productive T cell receptor rearrangements combined by the G..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Productive_T_cell_receptor_rearrangements_combined_by_the_GLIPH_algorithm_in_the_specificity_group_with_a_known_CDR3_peptide_binding_a_i_TP53_i_neoantigen_/21832451. , 2023
https://figshare.com/articles/journal_contribution/Productive_T_cell_receptor_rearrangements_combined_by_the_GLIPH_algorithm_in_the_specificity_group_with_a_known_CDR3_peptide_binding_a_i_TP53_i_neoantigen_/21832451. , 2023
?
7
Significant increase in overall survival in patients with a..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Significant_increase_in_overall_survival_in_patients_with_a_high_percentage_of_ascitic_fluid_cells_recovered_after_the_thawing_and_staining_process_/21832424. , 2023
https://figshare.com/articles/journal_contribution/Significant_increase_in_overall_survival_in_patients_with_a_high_percentage_of_ascitic_fluid_cells_recovered_after_the_thawing_and_staining_process_/21832424. , 2023
?
8
Association of pathologic conditions inferred from McPAS an..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Association_of_pathologic_conditions_inferred_from_McPAS_annotation_with_different_prognoses_according_to_the_Kruskal-Wallis_rank-sum_test_and_Dunn_test_/21832448. , 2023
https://figshare.com/articles/journal_contribution/Association_of_pathologic_conditions_inferred_from_McPAS_annotation_with_different_prognoses_according_to_the_Kruskal-Wallis_rank-sum_test_and_Dunn_test_/21832448. , 2023
?
9
Association of CD8+ T cell subsets and T cell receptor (TCR..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Association_of_CD8_T_cell_subsets_and_T_cell_receptor_TCR_characteristics_with_different_prognoses_using_the_Kruskal-Wallis_rank-sum_test_and_Dunn_test_/21832439. , 2023
https://figshare.com/articles/journal_contribution/Association_of_CD8_T_cell_subsets_and_T_cell_receptor_TCR_characteristics_with_different_prognoses_using_the_Kruskal-Wallis_rank-sum_test_and_Dunn_test_/21832439. , 2023
?
10
Usage of V gene segments originated known CDR3β peptide rec..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Usage_of_V_gene_segments_originated_known_CDR3_peptide_recognizing_TP53_epitope_in_22_patients_and_in_comparison_the_usage_calculated_for_all_CDR3_peptides_in_the_cohort_/21832433. , 2023
https://figshare.com/articles/journal_contribution/Usage_of_V_gene_segments_originated_known_CDR3_peptide_recognizing_TP53_epitope_in_22_patients_and_in_comparison_the_usage_calculated_for_all_CDR3_peptides_in_the_cohort_/21832433. , 2023
?
11
Gating strategy for the detection of different immune cell ..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Gating_strategy_for_the_detection_of_different_immune_cell_subsets_from_malignant_ascites_of_ovarian_cancer_patients_/21832415. , 2023
https://figshare.com/articles/journal_contribution/Gating_strategy_for_the_detection_of_different_immune_cell_subsets_from_malignant_ascites_of_ovarian_cancer_patients_/21832415. , 2023
?
12
Association of CDR3β peptides with prognosis and annotation..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/figure/Association_of_CDR3_peptides_with_prognosis_and_annotation_in_McPAS_and_VDJ_databases_/21832469. , 2023
https://figshare.com/articles/figure/Association_of_CDR3_peptides_with_prognosis_and_annotation_in_McPAS_and_VDJ_databases_/21832469. , 2023
?
13
S7 Table -:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/S7_Table_-/21832457. , 2023
https://figshare.com/articles/journal_contribution/S7_Table_-/21832457. , 2023
?
14
Sequence logo and phylogenetic tree of 41 CDR3β peptides id..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Sequence_logo_and_phylogenetic_tree_of_41_CDR3_peptides_identified_by_GLIPH_CD4_reference_as_a_specificity_group_with_a_known_peptide_CASSLVNTEAFF_that_binds_the_TP53_neoantigen_in_EOC_/21832427. , 2023
https://figshare.com/articles/journal_contribution/Sequence_logo_and_phylogenetic_tree_of_41_CDR3_peptides_identified_by_GLIPH_CD4_reference_as_a_specificity_group_with_a_known_peptide_CASSLVNTEAFF_that_binds_the_TP53_neoantigen_in_EOC_/21832427. , 2023
?
15
Difference in flow subset (expressed as a percentage of CD3..:
Kyoko Yoshida-Court (10231845) ; Tatiana V. Karpinets (10231842) ; Aparna Mitra (48628)...
https://figshare.com/articles/journal_contribution/Difference_in_flow_subset_expressed_as_a_percentage_of_CD3_live_lymphocytes_between_ascites_of_patients_grouped_in_Cluster_A_and_ascites_of_patients_grouped_in_the_remaining_clusters_others_/21832418. , 2023
https://figshare.com/articles/journal_contribution/Difference_in_flow_subset_expressed_as_a_percentage_of_CD3_live_lymphocytes_between_ascites_of_patients_grouped_in_Cluster_A_and_ascites_of_patients_grouped_in_the_remaining_clusters_others_/21832418. , 2023